3004.90.92.16/Rituximab 100mg/10ml Intravenous Infusion/Japan

Rituximab 100mg/10ml Intravenous Infusion from Japan

Rituximab is a monoclonal antibody antineoplastic used for non-Hodgkin lymphoma and rheumatoid arthritis, provided in 100mg/10ml single-use vials for measured IV administration. It qualifies under HTS 3004.90.92.16 as an immunosuppressive biologic in dosed form.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Provide BLA (Biologics License Application) details and lot release certificates from FDA

• Use validated shipping containers for biologics to maintain 2-8°C chain of custody